Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hensley

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Optics Letters|August 15, 2018
Differential phase-shift-keying demodulation by coherent perfect absorption in silicon photonicsAsif Ahmed, Hao Yang, Jacob M Rothenberg, et al.
Toxicologic Pathology|May 4, 2012
Off-target platelet activation in macaques unique to a therapeutic monoclonal antibodyMichael J Santostefano, Jacqueline Kirchner, Christine Vissinga, et al.
Molecular Cancer Therapeutics|February 17, 2023
SGN-CD228A Is an Investigational CD228-Directed Antibody-Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor ModelsRebecca Mazahreh, Marsha L Mason, John J Gosink, et al.
Nature Communications|May 2, 2025
LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancersChendi Li, Mohammed Usman Syed, Anahita Nimbalkar, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Optics Letters|August 15, 2018
Differential phase-shift-keying demodulation by coherent perfect absorption in silicon photonicsAsif Ahmed, Hao Yang, Jacob M Rothenberg, et al.
Toxicologic Pathology|May 4, 2012
Off-target platelet activation in macaques unique to a therapeutic monoclonal antibodyMichael J Santostefano, Jacqueline Kirchner, Christine Vissinga, et al.
Molecular Cancer Therapeutics|February 17, 2023
SGN-CD228A Is an Investigational CD228-Directed Antibody-Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor ModelsRebecca Mazahreh, Marsha L Mason, John J Gosink, et al.
Nature Communications|May 2, 2025
LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancersChendi Li, Mohammed Usman Syed, Anahita Nimbalkar, et al.
Pageof 7